SWK Holdings Corporation (SWK) announced that the company has submitted its formal application to list its common shares on the NASDAQ Capital Market. Concurrently, SWK announced the appointment of Winston Black, Chief Executive Officer of SWK, and Aaron G.L. Fletcher, Ph.D., to its Board of Directors. The appointments bring the total number of directors to six, of which three satisfy the independence requirements for service on the company's audit committee, including Dr. Fletcher. Dr. Fletcher currently serves as President of Bios Research. In addition to his position at Bios Research, Dr. Fletcher is a Managing Partner at Bios Partners, LP.